aTyr Pharma | LIFE - Selling And Administration Expenses


aTyr Pharma reported $4.8M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Alterity Therapeutics Limited AUD 2.29M 649.1K Jun/2023
Ardelyx USD 83.61M 378K Sep/2025
aTyr Pharma USD 4.8M 130K Sep/2025
Biogen USD 545.2M 38.6M Sep/2025
Bristol-Myers Squibb USD 2.18B 392M Dec/2025
Cipla INR 13.25B 101.8M Dec/2025
Clal Biotechnology ILS 3.31M 513K Dec/2022
Compugen USD 2.33M 50K Sep/2025
CSL USD 727M 453M Jun/2025
Curis USD 4.79M 100K Jun/2024
Galapagos EUR 34.55M 3.88M Sep/2025
GlaxoSmithKline GBP 2.68B 518M Dec/2025
Grifols EUR 333.1M 157M Sep/2025
Novartis USD 3.31B 134M Sep/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
United Therapeutics USD 152M 60.5M Sep/2025
Xoma USD 11M 2.54M Jun/2024